portal

  1. Presser

    daily subcutaneous injection, low-dose recombinant human IGF-I (40 micrograms/day)

    Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus.Dunger DB1, Cheetham TD. Author information Abstract<abstracttext>Growth hormone (GH) hypersecretion and relative insulin-like growth factor I (IGF-I) deficiency have been implicated in the development of...
    • Presser
    • Thread
    • daily diabetes gain growth hormone human hypoglycaemia iddm igf igf-i injection insulin insulin-dependent insulin-like levels low-dose peptide portal puberty recombinant reduce risk subcutaneous therapy weight
    • Replies: 0
    • Forum: Steroids SARMS Peptides Forum
Back
Top